"Organ Sparing Treatments" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Techniques, procedures, and therapies carried out on diseased organs in such a way to avoid complete removal of the organ and preserve the remaining organ function.
| Descriptor ID |
D059351
|
| MeSH Number(s) |
E02.674
|
| Concept/Terms |
Organ Sparing Treatments- Organ Sparing Treatments
- Organ Sparing Treatment
- Sparing Treatment, Organ
- Sparing Treatments, Organ
- Treatment, Organ Sparing
- Treatments, Organ Sparing
|
Below are MeSH descriptors whose meaning is more general than "Organ Sparing Treatments".
Below are MeSH descriptors whose meaning is more specific than "Organ Sparing Treatments".
This graph shows the total number of publications written about "Organ Sparing Treatments" by people in this website by year, and whether "Organ Sparing Treatments" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2014 | 2 | 1 | 3 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 3 | 4 |
| 2017 | 3 | 1 | 4 |
| 2018 | 4 | 2 | 6 |
| 2019 | 4 | 1 | 5 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
| 2023 | 0 | 3 | 3 |
| 2024 | 3 | 0 | 3 |
| 2025 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Organ Sparing Treatments" by people in Profiles.
-
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer. J Clin Oncol. 2025 Nov 10; 43(32):3536-3544.
-
Definitive intensity-modulated radiotherapy for organ preservation in vulvar cancer: A multicenter study. Gynecol Oncol. 2025 Aug; 199:1-9.
-
Parenchymal-sparing hepatectomy vs single-stage major hepatectomy for bilateral colorectal liver metastases: a higher rate of microscopically positive margins is not associated with increased local recurrence after parenchymal-sparing hepatectomy. J Gastrointest Surg. 2025 Jul; 29(7):102070.
-
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Gu?rin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing Therapies. Eur Urol Focus. 2025 May; 11(3):448-455.
-
Oncologic outcomes of pelvic organ-preserving radical cystectomy vs. Standard radical cystectomy: A systematic review and meta-analysis. Urol Oncol. 2025 05; 43(5):275-285.
-
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer. BJU Int. 2025 Feb; 135(2):260-268.
-
Bladder-sparing Therapy for Bacillus Calmette-Gu?rin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection. Eur Urol. 2024 Dec; 86(6):516-527.
-
Muscle-sparing Vertical Thoracotomy in Children and Adolescents. J Pediatr Surg. 2024 Oct; 59(10):161576.
-
Delivery outcomes in the subsequent pregnancy following the conservative management of placenta accreta spectrum disorder: a systematic review and meta-analysis. Am J Obstet Gynecol. 2024 05; 230(5):485-492.e7.
-
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048). J Clin Oncol. 2023 07 20; 41(21):3724-3734.